Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US Senators Question FDA's Pre-Cert Program Authority, Concerned About Safety

Executive Summary

Top Democratic lawmakers on the Senate HELP Committee have written to US FDA Commissioner Scott Gottlieb with questions about the agency's ongoing work to develop a pre-certification program that would allow medical software-makers to gain the agency's trust as a means to benefit from reduced or no pre-market review.


Related Content

2019 Will Be Testing Period For US FDA's Novel Pre-Cert Paradigm For Digital Health
3 Big Medtech Takeaways From US Midterms
US FDA's Software Pre-Cert Program: Is The Authority On The Books?
Size Doesn't Matter: US FDA Refines Dig-Health Pre-Cert Model
FDA Readies Digital Health Pre-Cert Program For Lift Off
Coming Together On Pre-Cert: Digital Health World Engages With FDA To Hash Out Regulatory Future
'Excellence' In Health-Software Design: US FDA Taps Nine Firms To Figure Out What That Means


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts